This observation is consistent with Wang et al., [31] reporting Cav-1 to not effect the constitutive activity (i.e. in the presence of ligand/serum) of ERK signalling in the RCC line, 786-O. This evidence concerns the gene CAV1 and renal cell carcinoma.